FDA approves first PSMA-targeted radiopharmaceutical

Nat Rev Drug Discov. 2022 May;21(5):327. doi: 10.1038/d41573-022-00067-5.
No abstract available

Publication types

  • News

MeSH terms

  • Humans
  • Radiopharmaceuticals* / therapeutic use

Substances

  • Radiopharmaceuticals